VNDA icon

Vanda Pharmaceuticals

99 hedge funds and large institutions have $348M invested in Vanda Pharmaceuticals in 2013 Q3 according to their latest regulatory filings, with 26 funds opening new positions, 44 increasing their positions, 19 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
99
Holders Change
+11
Holders Change %
+12.5%
% of All Funds
3.21%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
26
Increased
44
Reduced
19
Closed
14
Calls
$40.3M
Puts
$20M
Net Calls
+$20.3M
Net Calls Change
+$8.83M
Name Holding Trade Value Shares
Change
Shares
Change %
Two Sigma Investments
101
Two Sigma Investments
New York
-$1.49M -184,290 Closed
Susquehanna International Group
102
Susquehanna International Group
Pennsylvania
-$1.04M -129,035 Closed
EMG
103
Ellington Management Group
Connecticut
-$949K -117,400 Closed
SIM
104
Spark Investment Management
New York
-$926K -115,000 Closed
Balyasny Asset Management
105
Balyasny Asset Management
Illinois
-$848K -105,000 Closed
ISL
106
Ingalls & Snyder LLC
New York
-$694K -85,900 Closed
SM
107
Sabby Management
Florida
-$459K -56,843 Closed
Los Angeles Capital Management
108
Los Angeles Capital Management
California
-$340K -42,058 Closed
OC
109
Oppenheimer & Co
New York
-$323K -40,000 Closed
CCMH
110
Cornerstone Capital Management Holdings
New York
-$232K -28,604 Closed
MNBTD
111
Moody National Bank Trust Division
Texas
-$208K -25,755 Closed
BNP Paribas Financial Markets
112
BNP Paribas Financial Markets
France
-$97.6K -12,078 Closed
MWNA
113
Marshall Wace North America
New York
-$96K -11,856 Closed